Pathogenesis, classification and treatment of inflammatory myopathies (Q37862083)

24 August 2017

1 reference

title

Pathogenesis, classification and treatment of inflammatory myopathies (English)

1 reference

24 August 2017

0 references

0 references

2

Ingrid E Lundberg

1 reference

24 August 2017

Mei Zong

1

1 reference

24 August 2017

language of work or name

English

0 references

publication date

5 April 2011

1 reference

Nature Reviews Rheumatology

24 August 2017

published in

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

297-306

1 reference

Polymyositis, dermatomyositis and inclusion-body myositis

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis: implications for juvenile myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

How citation distortions create unfounded authority: analysis of a citation network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

The inflammatory milieu in idiopathic inflammatory myositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Activating NK-cell receptors co-stimulate CD4+CD28−T cells in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Induction and effector functions of T(H)17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

FOXP3+ T regulatory cells in idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Quantification and molecular characterization of regulatory T cells in connective tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Plasma cells in muscle in inclusion body myositis and polymyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Peripheral lymphoid tissue-like adhesion molecule expression in nodular infiltrates in inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

A local antigen-driven humoral response is present in the inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Treatment of adult inflammatory myositis with rituximab: an emerging therapy for refractory patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Polymyositis and pemphigus vulgaris in a patient: successful treatment with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Rituximab in life threatening antisynthetase syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Beta-chemokine receptor expression in idiopathic inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Autoantibody profiles in the sera of European patients with myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

21 January 2018

12 December 2020

Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Increased IL-15 production of muscle cells in polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Generation and growth of CD28nullCD8+ memory T cells mediated by IL-15 and its induced cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

The role of HMGB1 in the pathogenesis of rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Mechanisms of Disease: the role of high-mobility group protein 1 in the pathogenesis of inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Microvascular changes in skeletal muscle in idiopathic inflammatory myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Microvasculopathic neuromuscular diseases: lessons from hypoxia-inducible factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Extracellular high mobility group box chromosomal protein 1 is a coupling factor for hypoxia and inflammation in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Endoplasmic reticulum stress in disease: mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

The ER-bound RING finger protein 5 (RNF5/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Upregulation of MHC class I in transgenic mice results in reduced force-generating capacity in slow-twitch muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

The inhibition of apoptosis in myositis and in normal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Amyloid-β protein impairs Ca2+ release and contractility in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Impaired autophagy in sporadic inclusion-body myositis and in endoplasmic reticulum stress-provoked cultured human muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Polymyositis and dermatomyositis (first of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell-mediated muscle fiber injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Immunotherapy of myositis: issues, concerns and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Treatment of antisynthetase-associated interstitial lung disease with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Exercise effects in patients with adult idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

The possible role of physical exercise on the treatment of idiopathic inflammatory myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

A novel autoantibody to a 155-kd protein is associated with dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Activation of the endoplasmic reticulum stress response in autoimmune myositis: Potential role in muscle fiber damage and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

T Cell Infiltrates in the Muscles of Patients with Dermatomyositis and Polymyositis Are Dominated by CD28null T Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Expanded T cell receptor Vβ-restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Rituximab in the treatment of dermatomyositis: an open-label pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Expression of the beta chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Increased expression of beta-chemokines in muscle of patients with inflammatory myopathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Monocyte/macrophage differentiation in dermatomyositis and polymyositis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Clinical significance of anti-histidyl-tRNA synthetase (Jo1) autoantibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

[Inflammatory muscle diseases: dermatomyositis, polymyositis, and inclusion body myositis]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Le syndrome des anti-synthétases : un sous-groupe des myopathies inflammatoires à ne pas méconnaître

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Role of innate immunity in a murine model of histidyl-transfer RNA synthetase (Jo-1)-mediated myositis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Expression of tumor necrosis factor-alpha in muscles of polymyositis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

IL-6-deficient mice show impaired inflammatory response in a model of myosin-induced experimental myositis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Interleukin‐15 increases myosin accretion in human skeletal myogenic cultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Microvascular changes in early and advanced dermatomyositis: a quantitative study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Inflammatory myopathies with mitochondrial pathology and protein aggregates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

[Antisynthetase syndrome with good response to mycophenolate mofetil]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Rituximab as a first-line agent for the treatment of dermatomyositis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Antisynthetase syndrome with refractory polyarthritis and fever successfully treated with the IL-1 receptor antagonist, anakinra: A case report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.39

Serum levels of interleukin 15 in patients with rheumatic diseases

31 March 2020

1 reference

12 December 2020

Diagnostic value of MHC class I staining in idiopathic inflammatory myopathies.

1 reference

12 December 2020

Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases

1 reference

12 December 2020

Antisynthetase syndrome

1 reference

12 December 2020

Fatigue mechanisms in patients with cancer: effects of tumor necrosis factor and exercise on skeletal muscle

1 reference

12 December 2020

[The antisynthetase syndrome: a cause of rapidly progressive interstitial lung disease]

1 reference

12 December 2020

Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. A report of 4 cases and review of the literature

1 reference

12 December 2020

Classification criteria for polymyositis and dermatomyositis

1 reference

12 December 2020

Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2011.39

1 reference

Dimensions Publication ID

24 August 2017

1006894888

0 references

1 reference